TriMas Co. (NASDAQ:TRS – Get Free Report) declared a quarterly dividend on Thursday, February 20th, RTT News reports. Shareholders of record on Friday, February 28th will be given a dividend of 0.04 per share by the industrial products company on Friday, March 7th. This represents a $0.16 dividend on an annualized basis and a yield of 0.69%.
TriMas has increased its dividend by an average of 58.7% per year over the last three years.
TriMas Trading Down 1.6 %
NASDAQ TRS opened at $23.22 on Friday. The firm’s 50-day moving average is $24.21 and its two-hundred day moving average is $25.18. TriMas has a 12 month low of $22.24 and a 12 month high of $28.51. The company has a debt-to-equity ratio of 0.60, a current ratio of 2.83 and a quick ratio of 1.44. The stock has a market capitalization of $942.04 million, a P/E ratio of 36.28 and a beta of 0.66.
Wall Street Analysts Forecast Growth
Read Our Latest Stock Analysis on TRS
TriMas Company Profile
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
Read More
- Five stocks we like better than TriMas
- What is the Dow Jones Industrial Average (DJIA)?
- These 4 Low P/E Tech Stocks Could be Breakout-Ready Bargains
- How is Compound Interest Calculated?
- Palantir Stock Skids—How Much Further Can It Fall?
- CD Calculator: Certificate of Deposit Calculator
- Sudden Ascent: Is Recursion Pharmaceuticals NVIDIA’s AI Favorite?
Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.